Dermagraft-TC: Difference between revisions
m using singular name for category |
m wikify skin |
||
| Line 1: | Line 1: | ||
[[Image:Dermagraft.png|right|thumb|]] | [[Image:Dermagraft.png|right|thumb|]] | ||
'''Dermagraft-TC''' is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb | '''Dermagraft-TC''' is an artifical [[skin]] created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb | ||
|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | ||
|url=http://www.dermagraft.com/about/overview/ | |url=http://www.dermagraft.com/about/overview/ | ||
| Line 11: | Line 11: | ||
|accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> It is made and sold by [[Advanced Tissue Sciences]] (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb | }}</ref> It is made and sold by [[Advanced Tissue Sciences]] (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb | ||
|quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | |quote=...fibroblast-derived temporary [[skin]] substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. | ||
|url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | |url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | ||
|title=Dermagraft-TC | |title=Dermagraft-TC | ||
| Line 27: | Line 27: | ||
|date=2007-03-28 | |date=2007-03-28 | ||
|publisher=Transplant News | |publisher=Transplant News | ||
|quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved. | |quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary [[skin]] substitute to be approved. | ||
|accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal | }}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of [[skin]].<ref>{{REFjournal | ||
|last=Daecher | |last=Daecher | ||
|init=M | |init=M | ||